FDA.reportPublic FDA data

OXY Overnight Acne Reducing Patches

Product NDC
10742-8177
11-digit product format
107428177
Labeler code
10742
Product ID
10742-8177_f8f39dc2-9b76-4fd6-943d-bdef85acd95b
Type
HUMAN OTC DRUG
Nonproprietary name
salicylic acid
Dosage form
PATCH
Route
TOPICAL
Labeler
The Mentholatum Company
Application
part333D
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2018-01-01
Marketing end
0000-00-00
Substance
SALICYLIC ACID
Active strength
5 mg/1
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct10742-8177DDiscontinued by firm2026-10-05
excluded packagepackage10742-817710742-8177-1DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 2 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopeProduct NDCPackage NDCCodeStatusReporting periodArchiveSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproduct10742-8177DDiscontinued by firmexcluded / ndc_excluded.zipd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage10742-817710742-8177-1DDiscontinued by firmexcluded / ndc_excluded.zipd630ba8d3edf…732f749b63fb…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
10742-8177-12023-02-07C16284748780-1f386c64a-0a9a-0266-e053-dadaa90a7c1aDrug Facts - OXY Overnight Acne Reducing Patches
10742-8177-12023-01-30C16284748780-1f386c64a-0a9a-0266-e053-dadaa90a7c1aDrug Facts - OXY Overnight Acne Reducing Patches

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10742-8177OXY OVERNIGHT ACNE REDUCING PATCHES (SALICYLIC ACID) PATCH [THE MENTHOLATUM COMPANY]8Legacy NDC20241219_d9652f3f-bb6e-4d74-88d6-d4dbaa3de22d.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
10742-8177-11074281770130 PATCH in 1 PACKAGE (10742-8177-1) 30 patch2018-01-010000-00-00NoNoCurrent